BioCentury
ARTICLE | Company News

Inspire, Faes deal

November 6, 2006 8:00 AM UTC

FAE granted ISPH an exclusive license in the U.S. and Canada to develop and commercialize oral bilastine to treat or prevent rhinitis, as well as an exclusive license to the ocular formulation in var...